Nature · 2026
Tertiary lymphoid structures harbour stem-like tumour-specific T cells.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Afeyan Alexander B, Nagler Adi, Tu Chloe R, Roberti De Oliveira Gabriel, Simsek Berkay, Seager Maxwell D, El Ahmar Nourhan, Sax Haley E, Lin Emma, Sud Amit, Borji Mehdi, Forman Cleo, Liu Sophia, Ott Patrick A, Choueiri Toni K, Abelin Jennifer G, Burack Richard, Li Shuqiang, Livak Kenneth J, Tyekucheva Svitlana, Keskin Derin B, Chen Fei, Atkins Michael B, Simon Jeremy M, Signoretti Sabina, Oliveira Giacomo, Braun David A, Wu Catherine J
Аннотация
Tertiary lymphoid structures (TLSs) are associated with improved responses to immune checkpoint blockade across solid tumours1,2, but how they impact the phenotypic properties of tumour-specific T cells remains unclear. Here we found, across 24 treatment-naive renal cell carcinoma (RCC) tumours, that TLS-containing tumours are more heavily infiltrated by exhausted CD8+ T cells and have a reduced terminal exhaustion transcriptional program compared with TLS- tumours. Specificity screening of 554 T cell clonotypes expanded within the microenvironment of 6 RCC tumours revealed 82 TCRs that were reactive against tumour cells and/or RCC antigens. A subset of tumour-specific T cell clonotypes (12%) was enriched within TLSs, and these expressed an increased program of stem-like progenitor exhaustion, associated with favourable anti-tumour immunity. However, in 60 independent RCC tumours, macrophages within tumour margins of TLS-containing tumours had an inferred immunosuppressive phenotype and were colocalized with exhausted putative tumour-reactive T cells in a subgroup that was further analysed, therefore supporting this mode of immune evasion as a counterbalance to T cell immune pressure. Our data reveal that TLSs are reservoirs of tumour-specific T cells with stem-like progenitor features that could be leveraged by T cell immunotherapies.